Demographic data distribution and prospective survival outcomes of the cohort of women with estrogen receptor‐positive, human epidermal growth factor receptor‐2‐negative early‐stage invasive breast cancer whose primary tumors were examined by targeted sequencing for mutations. Here, ESR1 is linked to invasive breast carcinoma.